IBRX - ImmunityBio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$13.00
DETAILS
HIGH:
$15.00
LOW:
$12.00
MEDIAN:
$12.00
CONSENSUS:
$13.00
UPSIDE:
80.06%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 99.3% |
| EBIT Margin | -211.0% |
| EBITDA Margin | -197.3% |
| Operating Margin | -226.0% |
| Pretax Margin | -310.4% |
| Cont. Ops Margin | -310.2% |
| Net Margin | -310.2% |
| Bottom Line Margin | -310.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.10 |
| Quick Ratio | 5.08 |
| Solvency Ratio | -0.335 |
| Cash Ratio | 1.43 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-5.18
Peers avg: 20.6
|
| PEG Ratio | 0.15 |
| Forward PEG | 0.15 |
| Price/Book | -3.65 |
| Price/Sales | 16.08 |
| Price/FCF | -5.90 |
| Price/Op Cash Flow | -5.97 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 1.7496 |
| Debt/Equity | -1.7577 |
| Debt/Capital | 2.3197 |
| Long-Term Debt/Capital | 2.4887 |
| Financial Leverage | -1.00 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.59 |
| Operating Cash Flow Ratio | -4.938 |
| Operating Cash Flow/Sales | -269.2% |
| Free Cash Flow/Operating Cash Flow | 101.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -1.83 |
| Interest Coverage | -2.2753 |
| Short-Term Operating Cash Flow Coverage | -32.84 |
| Operating Cash Flow Coverage | -0.35 |
| Capital Expenditure Coverage | -79.29 |
| Dividend + Capital Expenditure Coverage | -79.29 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.12 |
| EPS | -0.382 |
| Debt/Share | 1.0769 |
| Cash/Share | 0.26 |
| Book Value/Share | -0.54 |
| Tangible BV/Share | -0.56 |
| Equity/Share | -0.54 |
| Operating Cash Flow/Share | -0.332 |
| Capital Expenditure/Share | 0.004 |
| FCF/Share | -0.336 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.999 |
| Earnings Before Tax/EBIT | 1.373 |
| Price/Fair Value | -3.65 |
| Debt/Market Cap | 0.4636 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -11.68 |